- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 137
PrecisionHawk clasps another $32m
The drone data software provider, which counts several corporates among its existing investors, has now disclosed $137m in overall funding.
Dec 12, 2019Sparkplus finds space for series B funding
The co-working space provider picked up $25.2m from backers including Asia Cement and founding investor Aju Hotels and Resorts.
Dec 12, 2019WhyHotel weighs $20m in series B funding
Berman Enterprises-backed Camber Creek returned to participate in a round that took the pop-up hotel operator’s overall funding to approximately $34m.
Dec 12, 2019Orange calls in on Intercloud
The cloud interconnect platform developer raised $24.2m from investors including Orange Digital Ventures, Open CNP, UL Invest and SNCF Digital Ventures.
Dec 12, 2019Mitsui enters Arcadia in $30m series C
Arcadia, the operator of a clean energy-sourcing platform for domestic use, boosted its overall equity funding to more than $62m in a Mitsui USA-backed round.
Dec 11, 2019Grupo Globo flings funding to Ingresse
Grupo Globo and Rival contributed to a $21.7m round for the online ticketing platform, whose past investors include Qualcomm and MercadoLibre.
Dec 10, 2019Jasper springs to life with $35m
Alexandria Venture Investments has backed a series A round for Jasper Therapeutics, which is developing a conditioning agent for patients awaiting stem cell transplants.
Dec 9, 2019Anaconda consumes $22m
Existing backer Banco Sabadell Venture Capital contributed to a round that will help the stroke surgery device developer fund clinical studies.
Dec 9, 2019Ribo rips into series C1 round
Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.
Dec 9, 2019Jasper springs to life with $35m
Building on translational science from Stanford, Jasper has secured funding to progress its Amgen-licensed conditioning agent for patients awaiting stem cell transplants.
Dec 9, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


